Examples of clinically relevant CYP inhibitors in the management of bipolar disorder include valproate (CYP2C9), risperidone (CYP2D6), and SSRI such as fluoxetine (CYP2D6). This evidence concerns the gene CYP2C9 and bipolar disorder.